Top and Current
Source: (remove) : Jeffrey Hung
RSSJSONXMLCSV
Top and Current
Source: (remove) : Jeffrey Hung
RSSJSONXMLCSV
Wed, August 7, 2024
Fri, July 12, 2024
Wed, March 13, 2024
Tue, December 19, 2023
Fri, December 8, 2023
Fri, November 3, 2023
Fri, August 4, 2023
Thu, August 3, 2023
Fri, July 14, 2023
Tue, July 11, 2023
Tue, March 14, 2023
Tue, February 28, 2023
Mon, January 30, 2023
Mon, September 12, 2022
Tue, August 9, 2022
Fri, July 15, 2022
Wed, May 11, 2022
Wed, April 6, 2022
Mon, February 14, 2022
Tue, December 7, 2021
Wed, November 24, 2021
Thu, October 14, 2021
Fri, August 13, 2021
Thu, August 5, 2021
Thu, May 6, 2021
Mon, April 19, 2021
Tue, April 6, 2021
Tue, March 9, 2021
Thu, February 25, 2021
Wed, February 3, 2021
Wed, December 16, 2020
Thu, November 5, 2020
Tue, October 13, 2020
Thu, August 20, 2020
Wed, April 15, 2020
Fri, March 27, 2020
Wed, March 4, 2020
Mon, October 28, 2019
Fri, October 11, 2019
Fri, July 12, 2019
Mon, September 10, 2018
Wed, February 21, 2018
Fri, February 2, 2018

Jeffrey Hung Downgraded (ACAD) to Hold and Decreased Target to $20 on, Aug 7th, 2024


Published on 2024-10-28 13:19:31 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold and Decreased Target from $28 to $20 on, Aug 7th, 2024.

Jeffrey has made no other calls on ACAD in the last 4 months.



There are 9 other peers that have a rating on ACAD. Out of the 9 peers that are also analyzing ACAD, 4 agree with Jeffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $22 on, Friday, May 10th, 2024
  • Uy Ear of "Mizuho" Maintained at Hold with Decreased Target to $21 on, Thursday, May 9th, 2024
  • Paul Matteis of "Stifel" Maintained at Hold with Decreased Target to $21 on, Thursday, May 9th, 2024
  • Jay Olson of "Oppenheimer" Maintained at Hold and Held Target at $19 on, Monday, May 6th, 2024


These are the ratings of the 5 analyists that currently disagree with Jeffrey


  • Keith Tapper of "BMO Capital" Initiated at Buy and Held Target at $31 on, Thursday, June 27th, 2024
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $27 on, Thursday, May 9th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy and Held Target at $30 on, Thursday, May 9th, 2024
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Thursday, May 9th, 2024
  • Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $27 on, Tuesday, April 30th, 2024